A guideline for economic evaluations of vaccines and immunization programs in China

H Fang, C Chen, Y Fang, X He, Z Hou… - Human vaccines & …, 2022 - Taylor & Francis
This study aimed to develop a consensus framework for economic evaluations of vaccines
as a national guideline in China. Some unique and important aspects were particularly …

Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies

W Shi, X Cheng, H Wang, X Zang, T Chen - BMJ open, 2021 - bmjopen.bmj.com
Objectives China suffers from high burdens of human papillomavirus (HPV) and cervical
cancer, whereas the uptake of HPV vaccine remains low. The first Chinese domestic HPV …

The lifetime cost estimation of human papillomavirus-related diseases in China: A modeling study

W Ding, Y Ma, C Ma, DC Malone, A Ma… - Journal of …, 2021 - degruyter.com
Objectives To estimate the lifetime treatment costs of patients with human papillomavirus
(HPV) infection-related diseases in China and to provide cost estimates for the economic …

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China

M Zou, H Liu, H Liu, M Wang, Z Zou… - Frontiers in …, 2023 - frontiersin.org
Background The 2021 Chinese Expert Consensus on the Clinical Application of the Human
Papillomavirus (HPV) Vaccine recommended vaccination for women who previously …

Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study

T You, X Zhao, C Pan, M Gao, S Hu, Y Liu… - The Lancet Regional …, 2024 - thelancet.com
Background The high price of HPV vaccines remains a significant barrier to vaccine
accessibility in China, hindering the country's efforts toward cervical cancer elimination and …

Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province …

Y Huang, D Zhang, L Yin, J Zhao, Z Li, J Lu, X Zhang… - Children, 2024 - mdpi.com
Low human papillomavirus (HPV) vaccine uptake is a key barrier to cervical cancer
elimination. We aimed to evaluate the health impact and cost-effectiveness of introducing …

[HTML][HTML] 中国人乳头瘤病毒感染相关疾病经济负担: 系统文献回顾和综合分析

贺妮楠, 邹卓如, 张云博, 何晓清, 熊苏嫱… - 中华疾病控制 …, 2023 - enzhjbkz.ahmu.edu.cn
中国人乳头瘤病毒感染相关疾病经济负担:系统文献回顾和综合分析 中国精品科技期刊 《中文
核心期刊要目总览》收录期刊 RCCSE 中国核心期刊(5/114,A+) Scopus收录期刊 美国《化学 …

[HTML][HTML] Targeting elimination of cervical cancer by 2030: a baseline assessment in six African countries—part II

DC Stefan, JM Dangou, P Barango… - …, 2022 - ncbi.nlm.nih.gov
Background Africa is home to many countries with the highest incidence of cervical cancer in
the world. It is encouraging to see that the efforts to prevent and manage this disease are …

[HTML][HTML] The Global Status of Universal Health Coverage and Oncology Care

KB Lankarani - Shiraz E-Medical Journal, 2022 - brieflands.com
: The reduction of preventable deaths from non-communicable diseases, including cancers,
is one of the main targets of universal health coverage. Not only there is a shortage of …

The Cost-Effectiveness of HPV Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn?–A Systematic Review

S Mongan, J Byrnes, H Kim - A Systematic Review, 2023 - papers.ssrn.com
Background: Cervical cancer is a significant health issue in Indonesia, with many patients
diagnosed with advanced-stage cancer. Human papillomavirus (HPV) vaccination has long …